Modified porphyrin–brucine conjugated to gold nanoparticles and their application in photodynamic therapy
Abstract
Two
* Corresponding authors
a
Department of Analytical Chemistry, Faculty of Chemical Engineering, Institute of Chemical Technology Prague, Technická 5, 166 28 Prague 6
E-mail:
kamil.zaruba@vscht.cz, pavel.rezanka@vscht.cz, lenka.veverkova@vscht.cz
Fax: +420-220-444-058
b
Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic
E-mail:
kralova@img.cas.cz
Fax: +420-241-063-586
c
First Faculty of Medicine, Charles University in Prague, Kateřinská 32, Prague 2, Czech Republic
E-mail:
pouckova@volny.cz
d
Zentiva Development (Part of sanofi-aventis Group), U Kabelovny 130, 10237Prague 10, Czech Republic
E-mail:
vladimir.kral@vscht.cz
Fax: +420-220-444-058
Two
K. Záruba, J. Králová, P. Řezanka, P. Poučková, L. Veverková and V. Král, Org. Biomol. Chem., 2010, 8, 3202 DOI: 10.1039/C002823A
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content